Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.78
Delayed Data
As of Mar 28
 -0.11 / -1.87%
Today’s Change
5.25
Today|||52-Week Range
15.00
+3.21%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.89
Today’s open5.89
Day’s range5.73 - 5.89
Volume82,929
Average volume (3 months)234,665
Market cap$149.9M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)+13.24%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.10-1.77%
PLXProtalix Biotherapeu...+0.07+5.98%
ASTAsterias Biotherapeu...+0.05+1.43%
GNCAGenocea Biosciences ...-0.08-1.40%
Data as of 03/28/2017

Financials

Next reporting dateJune 15, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs